User Settings
Open AccessArticle10.1038/eye.2015.58

Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

BevacizumabMedicineSerous fluidOphthalmologyInternal medicineChemotherapy

Chat

Click to start Chat